Post by Noel N.

Director/Senior Director, Quality Control & Analytical Development | Cell & Gene Therapy | AAV · LVV · CAR-T | CDMO Leadership | IND · BLA · MAA | FDA · EMA · MHRA | Inspection Readiness

Turnover was putting our programs at risk. Knowledge gaps were widening. Here is what we did about it and what I learned building the Flow Academy at Minaris Advanced Therapies." #CellAndGeneTherapy #QualityControl #Leadership #Biotech #ProfessionalDevelopment

Post content